Pregled bibliografske jedinice broj: 576587
Microvascular reactivity in subcutaneous and visceral fat tissue in human obesity
Microvascular reactivity in subcutaneous and visceral fat tissue in human obesity // The FASEB Journal (Meeting Abstract Supplement) 2012 ; 26
Miami (FL): Bethesda, MD : Federation of American Societies for Experimental Biology, 2012. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 576587 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Microvascular reactivity in subcutaneous and visceral fat tissue in human obesity
Autori
Grizelj, Ivana ; Čavka, Ana ; Bian, Jing-Tan ; Drenjančević, Ines ; Phillips, Shane A
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
The FASEB Journal (Meeting Abstract Supplement) 2012 ; 26
/ - Miami (FL) : Bethesda, MD : Federation of American Societies for Experimental Biology, 2012
Skup
Experimental Biology 2012
Mjesto i datum
San Diego (CA), Sjedinjene Američke Države, 21.04.2012. - 25.04.2012
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Microvascular Reactivity; Obesity
(microvascular reactivity; obesity)
Sažetak
Microvascular dysfunction contributes to cardiovascular disease risk during obesity. Prior data suggest that visceral adipose tissue (VAT) is associated to cardiometabolic risk factors and endothelial dysfunction compared subcutaneous adipose tissue (SAT). The aim of this study was to determine flow induced dilation (FID) in human VAT and SAT resistance arteries. We hypothesized that microvascular FID is impaired in VAT compared to SAT during obesity. Microvessels were obtained from VAT and SAT biopsies in lean (LN ; BMI<27) and during bariatric surgery (OB ; BMI>48). Isolated vessels were cannulated for vascular reactivity to flow (pressure gradient cmH2O, 20, 40, 60, 100) in the absence and presence of the NOS inhibitor L- NAME (10–4 M). Dilations to papaverine (10–4M) were determined in each vessel. FID was reduced in VAT (at 60, 59±7%, p<0.05) compared to SAT (at 60, 100±10%). Interestingly, FID was increased in SAT but not VAT from OB compared to LN subjects. There was no change in maximal dilation to papaverine between groups. In addition, there was no effect of L-NAME on FID in SAT of OB and LN. However, L- NAME reduced FID in VAT of OB (at 60, 36±8% ; p<0.05) vs. baseline. These data suggest that 1) FID is reduced in visceral compared to subcutaneous fat of obese patients and 2) NO mediates FID in microvessels from visceral but not subcutaneous adipose during obesity. NIH (K23HL085614, R01HL095701), UKF (87/11, 88/11).
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
219-2160133-2034 - Djelovanje kisika na vaskularnu funkciju u zdravlju i bolesti (Drenjančević, Ines, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Osijek
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE